Institutional update - Vækstfonden and Merlin announce partnership

Merlin Biosciences Limited (Merlin) and Vækstfonden, the largest provider of venture capital in Denmark, have announced a strategic partnership to explore investment opportunities within the Danish biotech industry. As part of this agreement, Vaekstfonden's fund-of-funds has invested in Merlin's latest fund, Merlin Biosciences Fund III. The investment represents Vaekstfonden's first investment in a venture capital fund outside Denmark. The aim of the alliance is to capitalise on Merlin's successes in guiding the development of start-up companies from seed investment through to market listing, and to apply that expertise to the Danish biotech sector.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• LPs
• Nordics